|
1
|
He X, Chang S, Zhang J, Zhao Q, Xiang H,
Kusonmano K, Yang L, Sun ZS, Yang H and Wang J: MethyCancer: the
database of human DNA methylation and cancer. Nucleic Acids Res.
36:D836–D841. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Salvesen GS and Abrams JM: Caspase
activation - stepping on the gas or releasing the brakes? Lessons
from humans and flies. Oncogene. 23:2774–2784. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shi Y: Caspase activation, inhibition, and
reactivation: a mechanistic view. Protein Sci. 13:1979–1987. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kumar S: Caspase function in programmed
cell death. Cell Death Differ. 14:32–43. 2007. View Article : Google Scholar
|
|
5
|
Friedlander RM: Apoptosis and caspases in
neurodegenerative diseases. N Engl J Med. 348:1365–1375. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kumar S and Dorstyn L: Analysing caspase
activation and caspase activity in apoptotic cells. Methods Mol
Biol. 559:3–17. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Siegel RM: Caspases at the crossroads of
immune-cell life and death. Nat Rev Immunol. 6:308–317. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Degterev A, Boyce M and Yuan J: A decade
of caspases. Oncogene. 22:8543–8567. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bodmer JL, Holler N, Reynard S,
Vinciguerra P, Schneider P, Juo P, Blenis J and Tschopp J: TRAIL
receptor-2 signals apoptosis through FADD and caspase-8. Nat Cell
Biol. 2:241–243. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ashkenazi A and Dixit VM: Apoptosis
control by death and decoy receptors. Curr Opin Cell Biol.
11:255–260. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Danial NN and Korsmeyer SJ: Cell death:
critical control points. Cell. 116:205–219. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang X, Miao X, Sun T, Tan W, Qu S, Xiong
P, Zhou Y and Lin D: Functional polymorphisms in cell death pathway
genes FAS and FASL contribute to risk of lung cancer. J Med Genet.
42:479–484. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
MacPherson G, Healey CS, Teare MD,
Balasubramanian SP, Reed MW, Pharoah PD, Ponder BA, Meuth M,
Bhattacharyya NP and Cox A: Association of a common variant of the
CASP8 gene with reduced risk of breast cancer. J Natl Cancer Inst.
24:1866–1869. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang M, Sun T, Wang L, Yu D, Zhang X, Miao
X, Liu J, Zhao D, Li H, Tan W and Lin D: Functional variants in
cell death pathway genes and risk of pancreatic cancer. Clin Cancer
Res. 14:3230–3236. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Von Elm E, Altman DG, Egger M, Pocock SJ,
Gøtzsche PC and Vandenbroucke JP; STROBE Initiative: The
Strengthening the Reporting of Observational Studies in
Epidemiology (STROBE) statement: guidelines for reporting
observational studies. Epidemiology. 18:800–804. 2007.
|
|
16
|
Zhang L, Liu JL, Zhang YJ and Wang H:
Association between HLA-B*27 polymorphisms and ankylosing
spondylitis in Han populations: a meta-analysis. Clin Exp
Rheumatol. 29:285–292. 2011.
|
|
17
|
Higgins JP and Thompson SG: Quantifying
heterogeneity in a meta-analysis. Stat Med. 21:1539–1558. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zintzaras E and Ioannidis JP:
Heterogeneity testing in meta-analysis of genome searches. Genet
Epidemiol. 28:123–137. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Peters JL, Sutton AJ, Jones DR, Abrams KR
and Rushton L: Comparison of two methods to detect publication bias
in meta-analysis. JAMA. 295:676–680. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Son JW, Kang HK, Chae MH, Choi JE, Park
JM, Lee WK, Kim CH, Kim DS, Kam S, Kang YM and Park JY:
Polymorphisms in the caspase-8 gene and the risk of lung cancer.
Cancer Genet Cytogenet. 169:121–127. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sun T, Gao Y, Tan W, Ma S, Shi Y, Yao J,
Guo Y, Yang M, Zhang X, Zhang Q, et al: A six-nucleotide
insertion-deletion polymorphism in the CASP8 promoter is associated
with susceptibility to multiple cancers. Nat Genet. 39:605–613.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cybulski C, Wokołorczyk D, Gliniewicz B,
Sikorski A, Górski B, Jakubowska A, Huzarski T, Byrski T, Debniak
T, Gronwald J, et al: A six-nucleotide deletion in the CASP8
promoter is not associated with a susceptibility to breast and
prostate cancers in the Polish population. Breast Cancer Res Treat.
112:367–368. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Frank B, Rigas SH, Bermejo JL, Wiestler M,
Wagner K, Hemminki K, Reed MW, Sutter C, Wappenschmidt B,
Balasubramanian SP, et al: The CASP8 −652 6N del promoter
polymorphism and breast cancer risk: a multicenter study. Breast
Cancer Res Treat. 111:139–144. 2008.
|
|
24
|
Li C, Zhao H, Hu Z, Liu Z, Wang LE,
Gershenwald JE, Prieto VG, Lee JE, Duvic M, Grimm EA and Wei Q:
Genetic variants and haplotypes of the caspase-8 and caspase-10
genes contribute to susceptibility to cutaneous melanoma. Hum
Mutat. 29:1443–1451. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pittman AM, Broderick P, Sullivan K,
Fielding S, Webb E, Penegar S, Tomlinson I and Houlston RS: CASP8
variants D302H and −652 6N ins/del do not influence the risk of
colorectal cancer in the United Kingdom population. Br J Cancer.
98:1434–1436. 2008.
|
|
26
|
Gangwar R, Mandhani A and Mittal RD:
Caspase 9 and caspase 8 gene polymorphisms and susceptibility to
bladder cancer in north Indian population. Ann Surg Oncol.
16:2028–2034. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang M and Zhang Z, Tian Y, Shao J and
Zhang Z: A six-nucleotide insertion-deletion polymorphism in the
CASP8 promoter associated with risk and progression of bladder
cancer. Clin Cancer Res. 15:2567–2572. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li C, Lu J, Liu Z, Wang LE, Zhao H,
El-Naggar AK, Sturgis EM and Wei Q: The six-nucleotide
deletion/insertion variant in the CASP8 promoter region is
inversely associated with risk of squamous cell carcinoma of the
head and neck. Cancer Prev Res (Phila). 3:246–253. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu B, Zhang Y, Jin M, Ni Q, Liang X, Ma
X, Yao K, Li Q and Chen K: Association of selected polymorphisms of
CCND1, p21, and caspase8 with colorectal cancer risk. Mol Carcinog.
49:75–84. 2010.PubMed/NCBI
|
|
30
|
Lv Z: Genetic polymorphisms in CASP8, Fas
and Fas ligand and the risk of peripheral T-cell lymphoma and the
relationship between the genetic polymorphisms and the clinical
characteristics and prognosis. Peking Union Medical College
Observational Studies. Epidemiology. 18:800–804. 2010.
|
|
31
|
Srivastava K, Srivastava A and Mittal B:
Caspase-8 polymorphisms and risk of gallbladder cancer in a
northern Indian population. Mol Carcinog. 49:684–692.
2010.PubMed/NCBI
|
|
32
|
Chatterjee K, Williamson AL, Hoffman M and
Dandara C: CASP8 promoter polymorphism is associated with high-risk
HPV types and abnormal cytology but not with cervical cancer. J Med
Virol. 83:630–636. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hart K, Landvik NE, Lind H, Skaug V,
Haugen A and Zienolddiny S: A combination of functional
polymorphisms in the CASP8, MMP1, IL10 and SEPS1 genes affects risk
of non-small cell lung cancer. Lung Cancer. 71:123–129. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kesarwani P, Mandal RK, Maheshwari R and
Mittal RD: Influence of caspases 8 and 9 gene promoter polymorphism
on prostate cancer susceptibility and early development of hormone
refractory prostate cancer. BJU Int. 107:471–476. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ma X, Zhang J, Liu S, Huang Y, Chen B and
Wang D: Polymorphisms in the CASP8 gene and the risk of epithelial
ovarian cancer. Gynecol Oncol. 122:554–559. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Theodoropoulos GE, Gazouli M, Vaiopoulou
A, Leandrou M, Nikouli S, Vassou E, Kouraklis G and Nikiteas N:
Poly morphisms of caspase 8 and caspase 9 gene and colorectal
cancer susceptibility and prognosis. Int J Colorectal Dis.
26:1113–1118. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Umar M, Upadhyay R, Kumar S, Ghoshal UC
and Mittal B: CASP8 −652 6N del and CASP8 IVS12-19G>A gene
polymorphisms and susceptibility/prognosis of ESCC: a case control
study in northern Indian population. J Surg Oncol. 103:716–723.
2011.
|
